Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma

References

• Adiwidjaja J, McLachlan AJ, Boddy AV. (2017). Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Expert Opin Drug Metab Toxicol 13:953–72.
   PubMed Web of Science ®Google Scholar
• AhmedRashed S, Hegazy HA, Mohamed A, Elmesallamy MW. (2016). Prognostic value of ALDH1, EZH2 and Ki-67 in astrocytic gliomas. Turk Patoloji Dergisi 32:70–81.
   PubMedGoogle Scholar
• Bose S, Panda AK, Mukherjee S, Sa G. (2015). Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div 10:6.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Brueckmann I, Scheel C, et al. (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 108:7950–5.
   PubMed Web of Science ®Google Scholar
• Cho SH, Hong JH, Noh YW, et al. (2016). Raspberry-like poly(gamma-glutamic acid) hydrogel particles for pH-dependent cell membrane passage and controlled cytosolic delivery of antitumor drugs. IJN 11:5621–32.
   Web of Science ®Google Scholar
• Chung SS, Vadgama JV. (2015). Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFkappaB signaling. Anticancer Res 35:39–46.
   PubMed Web of Science ®Google Scholar
• Duan J, Mansour HM, Zhang Y, et al. (2012). Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 426:193–201.
   PubMed Web of Science ®Google Scholar
• Fan Y, Li C, Li F, Chen D. (2016). pH-activated size reduction of large compound nanoparticles for in vivo nucleus-targeted drug delivery. Biomaterials 85:30–9.
   PubMed Web of Science ®Google Scholar
• Gao H, Qian J, Yang Z, et al. (2012). Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)–poly(epsilon-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy. Biomaterials 33:6264–72.
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Cao S, et al. (2014). Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Biomaterials 35:2374–82.
   PubMed Web of Science ®Google Scholar
• Gao J, Yu Y, Zhang Y, et al. (2012). EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials 33:270–82.
   PubMed Web of Science ®Google Scholar
• Gersey ZC, Rodriguez GA, Barbarite E, et al. (2017). Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer 17:99.
   PubMed Web of Science ®Google Scholar
• Gong C, Deng S, Wu Q, et al. (2013). Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34:1413–32.
   PubMed Web of Science ®Google Scholar
• Gong Z, Chen D, Xie F, et al. (2016). Codelivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cells. Nanomedicine (London) 11:2565–79.
   PubMed Web of Science ®Google Scholar
• Grantab R, Sivananthan S, Tannock IF. (2006). The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 66:1033–9.
   PubMed Web of Science ®Google Scholar
• Gu Y, Li J, Li Y, et al. (2016). Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer. IJN 11:5757–70.
   Web of Science ®Google Scholar
• Guo O, Li X, Yang Y, et al. (2014). Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core–shell drug-carrier based on heparin modified poly(l-lactide) grafted polyethylenimine cationic nanoparticles. J Biomed Nanotechnol 10:227–37.
   PubMed Web of Science ®Google Scholar
• Hunke H, Soin N, Shah TH, et al. (2015). Low-pressure H(2), NH(3) microwave plasma treatment of polytetrafluoroethylene (PTFE) powders: chemical, thermal and wettability analysis. Materials 8:2258–75.
   Web of Science ®Google Scholar
• Kakarala M, Brenner DE, Korkaya H, et al. (2010). Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122:777–85.
   PubMed Web of Science ®Google Scholar
• Kallifatidis G, Rausch V, Baumann B, et al. (2009). Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 58:949–63.
   PubMed Web of Science ®Google Scholar
• Ke XY, Ng VWL, Gao SJ, et al. (2014). Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials 35:1096–108.
   PubMed Web of Science ®Google Scholar
• Krause M, Dubrovska A, Linge A, Baumann M. (2017). Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Adv Drug Deliv Rev 109:63–73.
   PubMed Web of Science ®Google Scholar
• LiaoWang H, Deng Z, Ren Z, Li HX. (2015). Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway. Int J Clin Exp Med 8:8948–57.
   PubMed Web of Science ®Google Scholar
• Liu L, An M, Yang P, Zhang J. (2015). Superior cycle performance and high reversible capacity of SnO(2)/graphene composite as an anode material for lithium-ion batteries. Sci Rep 5:9055.
   PubMed Web of Science ®Google Scholar
• Mayer LD, Harasym TO, Tardi PG, et al. (2006). Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. Mol Cancer Ther 5:1854–63.
   PubMed Web of Science ®Google Scholar
• Mayer LD, Janoff AS. (2007). Optimizing combination chemotherapy by controlling drug ratios. Mol Intervent 7:216–23.
   PubMed Web of Science ®Google Scholar
• Mayer LD, Tai LC, Bally MB, et al. (1990). Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim Biophys Acta 1025:143–51.
   PubMed Web of Science ®Google Scholar
• Meng H, Wang M, Liu H, et al. (2015). Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano 9:3540–57.
   PubMed Web of Science ®Google Scholar
• Miller T, Hill A, Uezguen S, et al. (2012). Analysis of immediate stress mechanisms upon injection of polymeric micelles and related colloidal drug carriers: implications on drug targeting. Biomacromolecules 13:1707–18.
   PubMed Web of Science ®Google Scholar
• Misra R, Sahoo SK. (2011). Coformulation of doxorubicin and curcumin in poly(d, l-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 8:852–66.
   PubMed Web of Science ®Google Scholar
• Ochs CJ, Hong T, Such GK, et al. (2011). Dopamine-mediated continuous assembly of biodegradable capsules. Chem Mater 23:3141–3.
   Web of Science ®Google Scholar
• Patel KJ, Tannock IF. (2009). The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors. BMC Cancer 9:356.
   PubMed Web of Science ®Google Scholar
• Qi N, Tang B, Liu G, et al. (2017). Poly(γ-glutamic acid)-coated lipoplexes loaded with doxorubicin for enhancing the antitumor activity against liver tumors. Nanoscale Res Lett 12:361.
   PubMed Web of Science ®Google Scholar
• Ren Y, Wang R, Gao L, et al. (2016). Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy. J Control Release 228:74–86.
   PubMed Web of Science ®Google Scholar
• Shen S, Sun CY, Du XJ, et al. (2015). Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. Biomaterials 70:71–83.
   PubMed Web of Science ®Google Scholar
• Shi S, Shi K, Tan L, et al. (2014). The use of cationic MPEG-PCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin. Biomaterials 35:4536–47.
   PubMed Web of Science ®Google Scholar
• Singh A, Settleman J. (2010). EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29:4741–51.
   PubMed Web of Science ®Google Scholar
• Sobolewski C, Muller F, Cerella C, et al. (2015). Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model. Mol Carcinog 54:999–1013.
   PubMed Web of Science ®Google Scholar
• StevanovicKovacevic M, Petkovic B, Filipic J, Uskokovic MD. (2011). Effect of poly-alpha, gamma, l-glutamic acid as a capping agent on morphology and oxidative stress-dependent toxicity of silver nanoparticles. Int J Nanomed 6:2837–47.
   PubMed Web of Science ®Google Scholar
• Sun L, Deng X, Yang X, et al. (2014). Co-delivery of doxorubicin and curcumin by polymeric micelles for improving antitumor efficacy on breast carcinoma. RSC Adv 4:46737–50.
   Web of Science ®Google Scholar
• Sun R, Liu Y, Li SY, et al. (2015). Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells. Biomaterials 37:405–14.
   PubMed Web of Science ®Google Scholar
• Sun TM, Du JZ, Yao YD, et al. (2011). Simultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression. ACS Nano 5:1483–94.
   PubMed Web of Science ®Google Scholar
• Talelli M, Iman M, Varkouhi AK, et al. (2010). Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials 31:7797–804.
   PubMed Web of Science ®Google Scholar
• Wang BL, Shen YM, Zhang QW, et al. (2013). Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int J Nanomed 8:3521–31.
   PubMedGoogle Scholar
• Xu H, Cai C, Gou J, et al. (2015). Self-assembled monomethoxy (polyethylene glycol)-b-P(d, l-lactic-co-glycolic acid)-b-P(l-glutamic acid) hybrid-core nanoparticles for intracellular pH-triggered release of doxorubicin. J Biomed Nanotechnol 11:1354–69.
   PubMed Web of Science ®Google Scholar
• Xu H, Yang D, Cai C, et al. (2015). Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Acta Biomater 16:156–68.
   PubMed Web of Science ®Google Scholar
• Xu H-L, Fan Z-L, ZhuGe D-L, et al. (2017). Therapeutic supermolecular micelles of vitamin E succinate-grafted ε-polylysine as potential carriers for curcumin: enhancing tumour penetration and improving therapeutic effect on glioma. Colloids Surf B: Biointerfaces 158:295–307.
   PubMed Web of Science ®Google Scholar
• Xu HL, Mao KL, Lu CT, et al. (2016). An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. Biomaterials 107:44–60.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang C, Wang W, et al. (2016). Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep 6:21225.
   PubMed Web of Science ®Google Scholar
• ZhaoChen X, Liu Q, Li W, et al. (2015). Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. Int J Nanomed 10:257–70.
   PubMed Web of Science ®Google Scholar